OGEN Oragenics Forecast, Technical & Fundamental Analysis

a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis.

Industry Biotechnology

Get AI intraday signals

OGEN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For OGEN
(Try 14 days for Free)

View a ticker or compare two or three

Compare

OGEN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For OGEN
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

OGEN is expected to report earnings to fall 95.05% to -5 cents per share on May 15

Q1'23

Est.

$-0.05

Q4'22

Beat

by $1.39

Q3'22

Beat

by $0.02

Q2'22

Beat

by $0.01

Q1'22

Missed

by $0.03

The last earnings report on February 17 showed earnings per share of -100 cents, beating the estimate of -240 cents. With 312.24K shares outstanding, the current market capitalization sits at 3.83M.

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

1990 Main Street

Phone

+1 813 286-7900

Employees

Web

https://www.oragenics.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
RVLV	34.38	0.81	+2.41%
Revolve Group
IVVD	0.98	N/A	+0.46%
Invivyd
NOA	20.10	-0.42	-2.05%
North American Construction Group Ltd
BLD	360.00	-10.41	-2.81%
TopBuild Corp
MTNB	0.75	-0.15	-17.11%
Matinas Biopharma Holdings Inc

OGEN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OGEN has been loosely correlated with ATHA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OGEN jumps, then ATHA could also see price increases.

Ticker / NAME	Correlation To OGEN	1D Price Change %
OGEN	100%	-2.15%
ATHA - OGEN	34% Loosely correlated	+23.50%
SRPT - OGEN	30% Poorly correlated	-3.01%
CHRS - OGEN	27% Poorly correlated	+5.74%
RVNC - OGEN	26% Poorly correlated	+19.71%
RNA - OGEN	26% Poorly correlated	-0.76%
More